Device Trial Radar · NCT06560411
Evaluation of Auto-EPAP for Management of Upper Airway Obstruction During Non-Invasive Ventilation
Last checked: Nov 20, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Oct 3, 2024
Primary completion
Aug 7, 2025
Study completion Aug 7, 2025
Sponsor
- Lead sponsor
- Breas Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Veranex, Inc.
- First posted
- Aug 19, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and effectiveness of the Automatic Expiratory Positive Airway Pressure (Auto-EPAP) feature versus manual expiratory positive airway pressure (EPAP) in the Vivo 45 LS Ventilator.
Conditions
- Obstructive Sleep Apnea
- Obesity Hypoventilation Syndrome (OHS)
- Chronic Obstructive Pulmonary Disease (COPD)
- Neuromuscular Diseases (NMD)
Interventions
Non-Invasive VentilationDevice
Provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Exploratory effectiveness endpoint is to evaluate the subject's mean Oxygen Desaturation Index (ODI4%) during each overnight polysomnography assessment.Time frame: Up to Five Weeks
2 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Insomnia and Sleep Institute of Arizona, LLC
Scottsdale, Arizona
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.